FDA approves lipoatrophy filler.
D002482:Cellulose / Q000627:therapeutic use*; D003357:Cosmetic Techniques; D017277:Drug Approval; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy*; D006801:Humans; D019344:Lactic Acid / Q000627:therapeutic use*; D008353:Mannitol / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use*; D014481:United States
C482305:New-Fill; D011108:Polymers; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose